Pi Therapeutics lands $19.7 mln Series B
Pi Therapeutics, a preclinical-stage pharmaceutical company focused on treating cancer, has secured $19.7 million in Series B financing. Pontifax led the round.
31 May 2019•1 min read
Pi Therapeutics, a preclinical-stage pharmaceutical company focused on treating cancer, has secured $19.7 million in Series B financing. Pontifax led the round.
